4
Changes in Ownership
Nuvation Bio Inc. Filed Acc 0001415889-24-022940
CEO, ANHEART THERAPEUTICS LTD. acquired 4,239,300 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Wang Junyuan Jerry · CEO, ANHEART THERAPEUTICS LTD.
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-04 | Conversion : show line 1 in the form | +2,543,600 | 3,922,589 | D |
| 2024-09-04 | Conversion : show line 2 in the form | +1,695,700 | 2,246,458 | I |
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-03 | Grant or award : show line 3 in the form Series A Preferred Stock | +25,436 | 25,436 | D |
| 2024-09-03 | Grant or award : show line 4 in the form Series A Preferred Stock | +16,957 | 16,957 | I |
| 2024-09-03 | Grant or award : show line 5 in the form Warrants (Right to Buy) | +86,471 | 86,471 | D |
| 2024-09-03 | Grant or award : show line 6 in the form Warrants (Right to Buy) | +57,647 | 57,647 | I |
| 2024-09-04 | Conversion : show line 7 in the form Series A Preferred Stock | −25,436 | 0 | D |
| 2024-09-04 | Conversion : show line 8 in the form Series A Preferred Stock | −16,957 | 0 | I |
Loading xslF345X05/form4-09052024_080952.xml…